Suppr超能文献

肺内淋巴结(站 13 和 14)转移的周围型非小细胞肺癌。

Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer.

机构信息

Department of Thoracic Surgery.

Department of Traditional Chinese Medicine, The Bishan Hospital of Chongqing.

出版信息

Medicine (Baltimore). 2021 Jul 9;100(27):e26528. doi: 10.1097/MD.0000000000026528.

Abstract

It remains unknown whether dissecting the intrapulmonary lymph nodes (stations 13 and 14) when resecting peripheral non-small cell lung cancer (NSCLC) is necessary for accurate tumor node metastasis (TNM) staging. This study investigated intrapulmonary lymph node dissection (stations 13 and 14) on the pathological staging of peripheral NSCLC and the metastatic pattern of the lymph nodes.This retrospective study included patients with primary peripheral NSCLC who underwent radical dissection between January 2013 and December 2015. The clinical data of patients and examination results of intrapulmonary stations 12, 13, and 14 lymph nodes were analyzed.Of 3019 resected lymph nodes in a total of 234 patients (12.9/patient), 263 (8.7%) had metastasis. Ninety-nine patients had lymph node metastasis (42.3%): 40 (17.1%) were N1, 11 (4.7%) were N2, 48 (20.5%) were both N1 and N2, and 135 (57.7%) had no N1 or N2 metastasis. Sixteen (6.8%) patients had metastasis of stations 13 and/or 14. Metastasis in N1 positive patients of stations 10, 11, 12, 13, and 14 were 2.7%, 10.5%, 9.8%, 10.4%, and 8.5%, respectively. Missed detection without station 13 and 14 dissection was up to 6.8% (16/234).Dissection of stations 13 and 14 could be helpful for the identification of lymph node metastasis and for the accurate TNM staging of primary NSCLC.

摘要

对于周围型非小细胞肺癌(NSCLC),在切除时解剖肺内淋巴结(站 13 和 14)是否对准确的肿瘤淋巴结转移(TNM)分期有必要,目前尚不清楚。本研究旨在探讨肺内淋巴结解剖(站 13 和 14)对周围型 NSCLC 病理分期及淋巴结转移模式的影响。

这是一项回顾性研究,纳入了 2013 年 1 月至 2015 年 12 月期间接受根治性切除术的原发性周围型 NSCLC 患者。分析了患者的临床资料及肺内站 12、13 和 14 淋巴结的检查结果。

在 234 例患者的 3019 枚切除淋巴结中(每例 12.9 枚),有 263 枚(8.7%)发生转移。99 例患者发生淋巴结转移(42.3%):N1 期 40 例(17.1%),N2 期 11 例(4.7%),N1 和 N2 均有转移 48 例(20.5%),无 N1 或 N2 转移 135 例(57.7%)。16 例(6.8%)患者出现站 13 和/或 14 淋巴结转移。站 10、11、12、13 和 14 中 N1 阳性患者的转移率分别为 2.7%、10.5%、9.8%、10.4%和 8.5%。未行站 13 和 14 解剖时,漏检率高达 6.8%(16/234)。

因此,解剖站 13 和 14 有助于发现淋巴结转移,对原发性 NSCLC 的准确 TNM 分期有帮助。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27d9/8270592/00464417b694/medi-100-e26528-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验